Thursday, 15 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 29, 2026

Valero outlines $1.7B capital investment plan for 2026 while advancing optimization projects

View original at seekingalpha.com
Valero outlines $1.7B capital investment plan for 2026 while advancing optimization projects Earnings Call Insights: Valero Energy Corporation (VLO) Q4 2025 MANAGEMENT VIEW * Lane Riggs, CEO, President & Chairman, opened by noting "our continued commitment to safe, reliable and environmentally responsible operations re…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q4 2025 net income attributable to Valero stockholders was $1.1 billion or $3.73 per share

    80% confidence

  • The significant build in total light product inventory is attributed to high refinery utilization, not weak demand

    80% confidence

  • Demand is outpacing additional supply in light products

    80% confidence

  • Valero achieved a record for mechanical availability in 2025

    80% confidence

  • Valero captured favorable refining margins during Q4 driven by strong product cracks and widening sour crude discounts

    80% confidence

  • Increased Canadian and Venezuelan crude supply will benefit Valero

    80% confidence

  • Valero's return on share buybacks is above mid-teens over a 10-year period

    80% confidence

  • Venezuelan crude discounts look favorable heading into 2026

    80% confidence

  • Valero achieved record refining throughput and record ethanol production for both the fourth quarter and the full year 2025

    80% confidence

  • Valero has historically run as much as 240,000 barrels per day of Venezuelan heavy crude and expects increased processing capability

    80% confidence

  • Renewable diesel market will see 2026 starting off more like the second half of 2025, indicating a stronger year in 2026 versus 2025

    80% confidence

  • Valero returned $1.4 billion in cash to shareholders in Q4 2025 with a payout ratio of 66%

    80% confidence

  • Refining fundamentals are expected to remain supported by continued demand growth and tight supply environment driven by limited capacity additions

    80% confidence

  • Valero is committed to disciplined capital allocation framework that prioritizes balance sheet strength, disciplined capital investments and shareholder returns

    80% confidence

  • Refining throughput volumes in Q4 2025 averaged 3.1 million barrels per day or 98% throughput capacity utilization

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Valero outlines $1.7B capital investment plan for 2026 while advancing optimization projects — Source | Via News | ViaNews EU